Showing results (1-10 of 54) with videos related to
Sort By:
Pageof 6
Journal of Human Hypertension|March 24, 2007
Does the pulse pressure in people of European, African and South Asian descent differ? A systematic review and meta-analysis of UK dataC Agyemang, R Bhopal, W K RedekopPharmacoeconomics|June 1, 2001
Cost effectiveness of continuous terbinafine compared with intermittent itraconazole in the treatment of dermatophyte toenail onychomycosis: an analysis of based on results from the L.I.ON. study. Lamisil versus Itraconazole in OnychomycosisR Jansen, W K Redekop, F F RuttenPatient Preference and Adherence|May 17, 2021
Innovative Medical Technology and the Treatment Decision-Making Process in Multiple Sclerosis: A Focus Group Study to Examine Patient PerspectivesL A Visser, M De Mul, W K RedekopNetherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|March 5, 2013
Treatment costs of acute myocardial infarction in the NetherlandsR R Soekhlal, L T Burgers, W K Redekop, et al.Multiple Sclerosis and Related Disorders|January 12, 2020
Patient needs and preferences in relapsing-remitting multiple sclerosis: A systematic reviewL A Visser, C Louapre, C A Uyl-de Groot, et al.European Journal of Cancer (Oxford, England : 1990)|May 13, 2011
Critical review of economic evaluations in multiple myeloma: an overview of the economic evidence and quality of the methodologyJennifer G Gaultney, W K Redekop, Pieter Sonneveld, et al.Pharmacoeconomics|July 24, 2001
The cost effectiveness of tapered versus abrupt discontinuation of oral cyclosporin microemulsion for the treatment of psoriasisL Hakkaart-van Roijen, P Verboom, W K Redekop, et al.International Journal of Cardiology|September 14, 2014
Is it cost-effective to use a test to decide which individuals with an intermediate cardiovascular disease risk would benefit from statin treatment?L T Burgers, S T Nauta, J W Deckers, et al.Pageof 6